MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
Wang J, He AL, Zhang WG, Cao XM, Chen YX, Liu J, Zhao WH, Yang Y, Wang JL, Liu HL, Ma XR.
Wang J, et al. Among authors: liu j, liu hl.
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8057-8066. doi: 10.26355/eurrev_202008_22489.
Eur Rev Med Pharmacol Sci. 2020.
PMID: 32767332
Free article.